Auna SA

Auna SA (AUNA) Stock Analysis

$5.180

+0.071 (+1.37%)At close

Loading chart…
High
5.267
Open
5.160
VWAP
5.19
Vol
103.09K
Mkt Cap
Low
5.110
Amount
534.60K
EV/EBITDA, TTM
4.25

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia.

AI analysis of Auna SA (AUNA)

hold

Auna SA is currently a hold due to mixed signals in its financial performance and market sentiment. The current price is $5.18, which is below the analyst target of $5, indicating limited upside potential. The RSI is at 41.50, suggesting that the stock is nearing oversold territory, but it has not yet reached a strong buy signal. Furthermore, the company reported a 9% year-over-year revenue growth, but adjusted EBITDA declined by 9%, reflecting margin pressures. The main risk is the recent downgrade by JPMorgan, which highlights concerns over the company's financial outlook, particularly after a disappointing EPS surprise of -40% in the last earnings report.

Valuation Metrics

The current forward P/E ratio for Auna SA (AUNA) is 0.00, compared to its 5-year average forward P/E of 9.07.

Forward P/E

Strongly Undervalued
5Y Average P/E
9.07
Current P/E
0.00
Overvalued
11.35
Undervalued
6.78

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
5.10
Current EV/EBITDA
4.25
Overvalued
5.66
Undervalued
4.53

Forward P/S

Undervalued
5Y Average P/S
0.31
Current P/S
0.08
Overvalued
0.47
Undervalued
0.15

Events Timeline

2026-04-17 (ET)

08:50:00

Healthcare Services Peru Reports 4,855 Surgeries

2026-03-11 (ET)

12:00:00

Dow Jones Drops Over 400 Points Amid Oil Price Volatility

2026-03-10 (ET)

19:30:00

Trump's Mixed Messages on Middle East Impact Market Volatility

16:20:00

Auna Expects Approximately 12% Revenue Growth for FY 2026

16:20:00

Q4 Revenue Up 4% Year-over-Year

News

AUNA FAQ — answered by Alphio AI

Auna SA is a Luxembourg-based healthcare company. The Company has a patient- centric model providing prepaid healthcare plans, medical care, and oncology solutions, that promotes integrated healthcare system, healthy lifestyles through prevention, research, and education. It offers a wide-ranging practice and prospects that enables to deliver standard services and the possible patient outcomes. Its network includes nearly 31 healthcare network facilities, consisting of regional network of hospitals, clinics, outpatient, and wellness facilities with a total of 2,308 beds. It is also located in Mexico, Peru, and Colombia. It operates in the Healthcare sector.

Auna SA is currently a hold due to mixed signals in its financial performance and market sentiment. The current price is $5.18, which is below the analyst target of $5, indicating limited upside potential. The RSI is at 41.50, suggesting that the stock is nearing oversold territory, but it has not yet reached a strong buy signal. Furthermore, the company reported a 9% year-over-year revenue growth, but adjusted EBITDA declined by 9%, reflecting margin pressures. The main risk is the recent downgrade by JPMorgan, which highlights concerns over the company's financial outlook, particularly after a disappointing EPS surprise of -40% in the last earnings report.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started